By Everard L. Napier, M.R.C.S., L.R.C.P. (Lond.). In charge Kala-azar research, Calcutta School of Tropical Medicine. Second edition. 185 pages of text with 15 charts in the text, 18 plates, and an appendix of references to literature, author index and subject index. Oxford University Press. London, Bombay, Calcutta, Madras, 1927
Burkitt's Tumor Project, Department of Child Health, University of Ghana Medical School and National Cancer Institute, National Institutes of Health, Vector Biology and Control Division, Bureau of Tropical Diseases, Center for Disease Control, Accra, Ghana
Thirty-one (31) newborn infants living in Accra, Ghana, were visited monthly for the first 15 months of life to determine their serologic response to primary malaria infection. Only 10 episodes of seroconversion were observed, the earliest occurring at the 5th month and at a time when maternal-acquired antibodies were absent. Following seroconversion, antibody titers peaked at the 1st month but were generally of low titer (mean geometric titers <1:80) and declined to undetectable levels within a few months. The majority of the seroconverting infants had no symptoms of illness although in three of the 10 episodes splenic enlargement was noted. This study suggests that symptoms of malaria infection in infancy are often minimal, but that the moderation of symptoms is due to factors other than maternally transmitted antimalarial antibodies. Additionally, malaria appears to be much less common than expected in this urban area of West Africa.
Present address: Environmental Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20205.